product summary
Loading...
company name :
R&D Systems
product type :
ELISA/assay
product name :
Quantikine Immunoassay Control Set 1060 for HS Human G-CSF
catalog :
QC97
quantity :
1 Each
price :
170 USD
more info or order :
product information
brand :
R&D Systems
master code :
QC97
SKU :
QC97
product name :
Quantikine Immunoassay Control Set 1060 for HS Human G-CSF
unit size :
1 Each
seo description :
The Quantikine Immunoassay Control Set 1060 for HS Human G-CSF from R&D Systems quantifies human G-CSF.
target :
G-CSF
category :
ELISAs
dilution :
Control
species :
Human
gene symbol :
CSF3
url print :
?utm_source=biocompare&utm_medium=referral&utm_campaign=product&utm_term=elisas
applications :
Control
extended description :
For use with catalog number HSTCS0
USD :
170 USD
product details :
For use with catalog number HSTCS0
alt names :
C17orf33, chromosome 17 open reading frame 33, colony stimulating factor 3 (granulocyte), CSF3, CSF3OS, Filgrastim, GCSF, G-CSF, GCSFlenograstim, granulocyte colony-stimulating factor, Lenograstim, MGC45931, pluripoietin
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
- Quantikine Immunoassay Control Set 765 for Human CA125/MUC16 | QC56
- Quantikine Immunoassay Control Set 855 for Human Calbindin D | QC189
- Quantikine Immunoassay Control Set 717 for Human Mesothelin | QC225
- Quantikine Immunoassay Control Set 775 Human Caspase-1/ICE | QC57
- QuantiGlo Immunoassay Control Set 732 for Human IL-1 beta | QC190
questions and comments